Celiac Disease Is Associated with Microscopic Colitis in Refractory Cases in Adults: A Systematic Review and Meta-Analysis of Observational Studies.

Muhammad Aziz, Hossein Haghbin, Raja Samir Khan, Zubair Khan, Simcha Weissman, Faisal Kamal, Wade Lee-Smith, Saurabh Chandan, Joseph D Feuerstein, Douglas G Adler

Journal: Digestive diseases and sciences 2022;67(8):3529-3542

PMID: 34448981

Abstract

BACKGROUND

Microscopic colitis and Celiac disease have been shown to occur concomitantly, but their relationship has yet to be systematically evaluated. Some patients with refractory microscopic colitis may have simultaneous celiac disease, and the converse is also true.

AIMS

We performed a systematic review and meta-analysis of observational studies to assess the prevalence and possible association between these two conditions.

METHODS

PubMed, Embase, Cochrane, Web of Science, SciELO, and CINAHL Plus were systematically searched through January 26, 2021, to include relevant observational studies assessing the prevalence of microscopic colitis in celiac disease population or vice versa. DerSimonian-Laird approach using random effects was used to pool data and compare outcomes. Pooled prevalence, 95% confidence interval (CI), and p values (where applicable) were calculated.

RESULTS

Five studies (with 2589 patients, age range 39.5-52 years and females 66.6%) and 21 studies (with 7186 patients, age range 46.4-65.8 years and females 76.3%) were included assessing the prevalence of microscopic colitis in refractory celiac disease and celiac disease in refractory microscopic colitis cohort. The overall prevalence was 4.5% (2.6-6.3%) and 6.7% (5.2-8.1%), respectively. Five studies showed higher odds of celiac disease diagnosis in the refractory microscopic colitis population compared to the control group (OR 8.12, CI 4.92-13.41, p < 0.001).

CONCLUSION

Celiac disease and microscopic colitis are concomitantly prevalent in a subset of population with either refractory diagnosis. Clinicians should explore alternate diagnosis when one condition has been appropriately treated and patients continue to have refractory symptoms.

© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Address: Division of Gastroenterology and Hepatology, University of Toledo, Toledo, OH, USA.; Department of Internal Medicine, University of Toledo, Toledo, OH, USA.; Department of Internal Medicine, West Virginia University, Morgantown, WV, USA.; Division of Gastroenterology and Hepatology, University of Texas at Houston, Houston, TX, USA.; Department of Medicine, Hackensack University - Palisades Medical Center, North Bergen, NJ, USA.; Division of Gastroenterology, University of California, San Francisco, CA, USA.; University of Toledo Libraries, University of Toledo, Toledo, OH, USA.; Gastroenterology Unit, CHI Health Creighton University Medical Center, Omaha, NE, USA.; Division of Gastroenterology, Hepatology, and Nutrition, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Department of Gastroenterology, Centura Health, Center for Advanced Therapeutic Endoscopy, Denver, CO, USA. [email protected].

Link outs

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.